Urology Today.net

Site updated at Wednesday, 26 November 2014

Common Urological Problems

Jevtana

J&J drug offers hope in advanced prostate cancer

Men with advanced prostate cancer lived nearly four months longer on a new pill from Johnson & Johnson, according to keenly awaited study data that researchers said would change clinical practice.

Abiraterone, which could reach the market next year, provides a new option for men with an aggressive type of prostate cancer.

Its… J&J drug offers hope in advanced prostate cancer   



yervoy1 - concentrated urine1 - bju international1 - metabolic evaluation1 - conventional ultrasound1 - university of alabama at birmingham1 - urological diseases1 - end-stage kidney failure2 - interstitial cystitis2 - ureteral edema1 - urinary stones6 - plco study1 - renal calculi1 - calcium nephrolithiasis3 - kidney removal1 - uroflowmetry1 - rituximab1 - malaria1 - urinary ions2 - prostate cancer risk1 - uterine cancer2 - sudden-onset headache1 - inf21 - radial nephrotomy1 - glomerulosclerosis1 - catheter-associated urinary tract infection1 - matrix component3 - thomas jefferson university hospital2 - prostate cancer screening7 - renal fibrosis1 -